Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2Phase 4 1

Status

Recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Plasma cell 1Lymphoid 1

Conditions

Breast Neoplasms 171Neoplasms 137Prostatic Neoplasms 77Lung Neoplasms 69Colorectal Neoplasms 68Motor Activity 39Uterine Cervical Neoplasms 36Pancreatic Neoplasms 30Head and Neck Neoplasms 28Ovarian Neoplasms 27Brain Neoplasms 27Carcinoma, Non-Small-Cell Lung 23Rectal Neoplasms 21Glioblastoma 21Carcinoma, Hepatocellular 21Colonic Neoplasms 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Stomach Neoplasms 16Hematologic Neoplasms 16Disease 16Depression 16Anxiety Disorders 16Papillomavirus Infections 14Melanoma 14Leukemia 14Multiple Myeloma 13Glioma 13Squamous Cell Carcinoma of Head and Neck 12Carcinoma, Renal Cell 12Urinary Bladder Neoplasms 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Cytokine Release Syndrome × 30 days × Clear all
NCT07499128 2026-06-01

Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

National Institutes of Health Clinical Center (CC)

Phase NA Enrolling by invitation
136 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Cytokine Release Syndrome, Lymphoma, Multiple Myeloma, Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06377059 2026-05-15

Early Detection of Complications During Immunotherapy for Haematological Malignancy

Rigshospitalet, Denmark

Phase NA Recruiting
100 enrolled
Other hematologic neoplasm

Cytokine Release Syndrome, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡